With cannabinoids over nervousness and nervous problems
Stressful life, rush, poor quality food, emotional distress, exhaustion at work, lack of sleep and rest... All of this affects both women's and men's nervous systems. How can we support it naturally, with cannabis cannabinoids?
Increasing research into the endocannabinoid system, the function of which is supported by cannabis cannabinoids (CBD, CBG, etc.), is revealing the many potential benefits of taking cannabinoids for our health and well-being. Among these are the beneficial effects of cannabinoids on the health of the central and peripheral nervous systems.
According to the data American research conducted in 2019, the most common reasons people choose to take the cannabinoid CBD include nervousness, tension, stress, anxiety and insomnia. This means that many people use CBD as a welcome counterbalance to a psychophysically stressful lifestyle, as it offers mental and physical relaxation, helps in managing anxiety, [1] makes it easier to overcome stressful situations, and also improves concentration and memory, and contributes to better sleep quality. Many of these effects are due to the positive influence of cannabinoids on the nervous system.
There are also an increasing number of people who are deciding to support their bodies by taking cannabinoids in the hope that they will prevent or even alleviate more serious problems of the nervous system, such as depression, dementia, Alzheimer's disease, Parkinson's disease, epilepsy, etc.
The research to date in this direction is promising. It is known that cannabinoids such as CBD and CBG, which are found in the innovative preparation CBDex® NEURO 4%+1%, support the health of the nervous system. Cannabinoids prevent damage to the nervous system through various mechanisms: they neutralize free radicals, reduce inflammation, improve the function of mitochondria (the power plants of the cells), remove the beta amyloid protein, and also help cells eliminate waste products. Since Alzheimer's disease is characterized by the accumulation of beta amyloid protein in the brain and the associated inflammation of the brain, Dr. David Schubert rightly sees therapeutic potential in cannabis cannabinoids for the treatment of this disease.[2]
Brazilian researchers, for example, also see potential in the cannabinoid CBD for treating Parkinson's disease, as they found that CBD at a dose of 20 mg/kg of body weight limits the loss of dopaminergic neurons in parts of the brain affected by this disease.
[1] Esther M. Blessing et al., “Cannabidiol as a Potential Treatment for Anxiety Disorders.
[2] Antonio Currais et al., "Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids".
Text: Adriana Dolinar, Ph.D.Vet.Med., the president Associations for the Awakening of the Whole Man and an external employee of the information center - Zadravje.net.
Source: https://www.zazdravje.net/zdrava-medicina/s-kanabinoidi-nad-zivcnost-in-zivcne-tezave/
